Literature DB >> 10456950

Inhibitory effects of protamines on proteolytic and adhesive activities of Porphyromonas gingivalis.

M Kontani1, A Amano, T Nakamura, I Nakagawa, S Kawabata, S Hamada.   

Abstract

Protamines (salmine prepared from sperm DNA of salmon and clupeine from herring sperm), which are basic peptides rich in arginine, were found to inhibit the proteolytic activity of arginine-specific cysteine protease (RC-protease) from Porphyromonas gingivalis. Lineweaver-Burk plot analysis revealed that the protamines competitively inhibited proteolytic activity with cleavage of benzoyl-L-arginine-p-nitroanilide, a synthetic substrate of RC-protease. Furthermore, the protamines were capable of binding strongly to P. gingivalis fimbriae and inhibited fimbrial interaction with immobilized fibronectin. These results clearly show that protamines are potent inhibitors of the proteolytic and adhesive activities of P. gingivalis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10456950      PMCID: PMC96828     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Porphyromonas gingivalis fimbrillin is one of the fibronectin-binding proteins.

Authors:  Y Murakami; H Iwahashi; H Yasuda; T Umemoto; I Namikawa; S Kitano; S Hanazawa
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Protamine-induced permeabilization of cell envelopes of gram-positive and gram-negative bacteria.

Authors:  C Johansen; A Verheul; L Gram; T Gill; T Abee
Journal:  Appl Environ Microbiol       Date:  1997-03       Impact factor: 4.792

3.  Binding of Porphyromonas gingivalis fimbriae to proline-rich glycoproteins in parotid saliva via a domain shared by major salivary components.

Authors:  A Amano; S Shizukuishi; H Horie; S Kimura; I Morisaki; S Hamada
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 4.  The importance of fimbriae in the virulence and ecology of some oral bacteria.

Authors:  S Hamada; A Amano; S Kimura; I Nakagawa; S Kawabata; I Morisaki
Journal:  Oral Microbiol Immunol       Date:  1998-06

5.  Adherence of Porphyromonas gingivalis to matrix proteins via a fimbrial cryptic receptor exposed by its own arginine-specific protease.

Authors:  M Kontani; S Kimura; I Nakagawa; S Hamada
Journal:  Mol Microbiol       Date:  1997-06       Impact factor: 3.501

Review 6.  Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease.

Authors:  C A Genco; J Potempa; J Mikolajczyk-Pawlinska; J Travis
Journal:  Clin Infect Dis       Date:  1999-03       Impact factor: 9.079

7.  Changes in cell morphology of Listeria monocytogenes and Shewanella putrefaciens resulting from the action of protamine.

Authors:  C Johansen; T Gill; L Gram
Journal:  Appl Environ Microbiol       Date:  1996-03       Impact factor: 4.792

8.  Cysteine protease of Porphyromonas gingivalis 381 enhances binding of fimbriae to cultured human fibroblasts and matrix proteins.

Authors:  M Kontani; H Ono; H Shibata; Y Okamura; T Tanaka; T Fujiwara; S Kimura; S Hamada
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Construction and characterization of arginine-specific cysteine proteinase (Arg-gingipain)-deficient mutants of Porphyromonas gingivalis. Evidence for significant contribution of Arg-gingipain to virulence.

Authors:  K Nakayama; T Kadowaki; K Okamoto; K Yamamoto
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

10.  Polyamines found in gingival fluid inhibit chemotaxis by human polymorphonuclear leukocytes in vitro.

Authors:  J D Walters; T J Miller; A C Cario; F M Beck; P T Marucha
Journal:  J Periodontol       Date:  1995-04       Impact factor: 6.993

View more
  1 in total

1.  Propeptide-mediated inhibition of cognate gingipain proteinases.

Authors:  N Laila Huq; Christine A Seers; Elena C Y Toh; Stuart G Dashper; Nada Slakeski; Lianyi Zhang; Brent R Ward; Vincent Meuric; Dina Chen; Keith J Cross; Eric C Reynolds
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.